beta-Fuoxymorphamine

beta-Fuoxymorphamine (β-fuoxymorphamine) is an opioid acting at μ-opioid receptors. It is used experimentally.[1]

beta-Fuoxymorphamine
Names
IUPAC name
Methyl (2E)-4-{[(5α,6β)-3,14-dihydroxy-17-methyl-4,5-epoxymorphinan-6-yl]amino}-4-oxo-2-butenoate
Identifiers
3D model (JSmol)
Abbreviations β-FOA
ChEMBL
ChemSpider
Properties
C22H26N2O6
Molar mass 414.458 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

See also

References

  1. Huang, Weijiao; Manglik, Aashish; Venkatakrishnan, A. J.; Laeremans, Toon; Feinberg, Evan N.; Sanborn, Adrian L.; Kato, Hideaki E.; Livingston, Kathryn E.; Thorsen, Thor S.; Kling, Ralf C.; Granier, Sébastien; Gmeiner, Peter; Husbands, Stephen M.; Traynor, John R.; Weis, William I.; Steyaert, Jan; Dror, Ron O.; Kobilka, Brian K. (2015). "Structural insights into µ-opioid receptor activation". Nature. 524 (7565): 315–321. doi:10.1038/nature14886. PMC 4639397. PMID 26245379.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.